Search Results

activity and working backward to define receptor biology has proven to be a productive strategy for de-orphanization As assay technologies continue to evolve and as the de-orphanization of GPCR pharmacology  accelerates

train in veterinary medicine, where he was introduced to physiology and pharmacology  for the first time Those courses didn’t feel like career-defining moments at the time — just requirements to pass. Emerging direction: Treatment sequencing + guided de-escalation.

techniques used in HTS, among them Fluorescence Polarization (FP) is especially useful since it allows real time Not time-sensitive Once equilibrium has been reached the assay remains stable for extended periods (at L, González A, Gioé-Gallo C, Mallo-Abreu A, Brea J, Loza MI, García-Rey A, García-Mera X, Gutiérrez-de-Terán

conjugation technology enabled the design and synthesis of numerous exploratory compounds in a short time Raïch, I.; Rivas-Santisteban, R.; Lillo, A.; Lillo, J.; Reyes-Resina, I.; Nadal, X.; Ferreiro-Vera, C.; De I.; García-Rey, A.; García-Mera, X.; Gutiérrez-de-Terán, H.; Sotelo, E.

But Carlsson doesn’t try to do everything under one roof. Over time, that transparency has built enduring partnerships , including one of Carlsson’s earliest with In practice, this approach saves companies time, resources, and credibility with investors. Carlsson’s lab is a proof point : collaboration is not just a cultural preference.

Hi GPCR Fanatics,   This week’s insights will help you avoid wasted time, poor forecasts, and stalled costly errors:  Master vital models to confidently forecast outcomes, before it’s too late. ✅ Future-proof

a patch of fluorescence — the entire pancreatic islet , 100–200 microns across, lighting up in real time It wasn’t just successful GPCR imaging — it was proof that receptors could be seen as they truly exist Not one receptor at a time. Not one color. Not one imaging depth. It was the proof of concept.

notable differences in respect to neural network architecture, complexity, data requirements, training time DL models generally require more computational resources (such as powerful GPUs) and longer training times De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding chemical space, limiting their ability to identify truly novel chemotypes”(Thomas, Smith, O’Boyle, de

This week's highlight includes congrats to Omolade Otun, Chris de Graaf, Cherine Bechara, et al. for Understanding real-time kinetics to predict activity and in vivo target coverage.

membrane-embedded opsin indicated that phospholipid headgroups traverse a dynamically revealed hydrophilic groove cholesterol inhibits phospholipid scrambling by occupying the TM6/7 interface and stabilizing the closed groove

environment — supporting scientific reasoning as programs mature, rather than treating pharmacology as a one-time evolving data — from Schild slope interpretation to probe dependence and kinetic validation — in real time suggest occupancy-limited modulation Linear plots with slope ≠ 1 demand investigation  — equilibration time changes in association or dissociation rates moves analysis beyond functional shifts toward mechanistic proof Repetition without purpose consumes time. Statistical rigor prevents wishful interpretation.

running early-stage programs, recognizing this decoupling early can sharpen dose optimization  and de-risk

Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation

Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance

As well, fluorescent ligands were effective at monitoring real-time A2BAR receptor labeling using live-imaging This proof-of-concept study suggests the use of fluorescent ligands for GPCR characterization through

Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics

GPCR drugmaker Septerna amasses $288M in IPO Surrounded by AI bio giants, tiny startup Nabla Bio makes de

Terry also explores the experimental constraints —like timing and equilibrium—that determine whether Unlock “Competitive Antagonism” Now Only in Terry’s Corner Why Terry’s Corner For discovery-phase teams, time But Terry cautions: “These patterns are consistent with, but not proof of, mechanism.

Adhesion GPCRs Optimized genetic code expansion technology for time-dependent induction of adhesion GPCR-ligand ended 31 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based de

Learn how to transform your program from a series of disconnected efforts into a predictable, de-risked

dynamics simulations of opsin in a lipid membrane reveal conformational transitions that expose a polar groove This groove enables transbilayer lipid movement, conceptualized as the swiping of a credit card (lipid

This week's highlight includes congrats to: Tessa de Vries, Graham Ladds, Antoinette MaassenVanDenBrink

Topics cover new cellular assays, real-time kinetics, and unique GPCR behaviors. GPR37-mTOR-S6K1 Signaling GPCRs in Neuroscience Astrocyte Gi-GPCR signaling corrects compulsive-like grooming

Our work provides proof of concept for the modulation of isoform- and ligand specific aGPCR functions

The researchers conducted a comparative analysis with previous studies, notably the work by Groot-Kormelink

November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd

Venture-like’ capital allocation approach to focus pipeline development through to Phase 1b/2a clinical proof

By making receptor behavior computationally predictable, Ajay and his team are working to reduce the time Ajay's career is proof that in science, the detours are often the real path forward

In a proof-of-principle study, we succeeded in showing that our CCR9-PROTAC is able to reduce CCR9 levels

Clinical development times for innovative drugs. Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography Protein Eng Des Sel. 2016;29(12):583-594. 47.         Crilly SE, Ko W, Weinberg ZY,Puthenveedu MA.